explore -WSS

explore

author：hotspot 2025-09-27 23:52:09 - browse：6657

Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit. — Priscilla Chan and Mark Zuckerberg appear virtually at the 2023 STAT Summit. STAT

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease.

The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. It joins the original San Francisco Biohub founded in 2016 and a Chicago Biohub founded earlier this year.

“About the five-year mark, we basically sat down and tried to assess what we thought was working well and what we want to double down on,” Zuckerberg told STAT. “And we thought that the Biohub model to bring a few universities together, coupling that with engineering and a long-term goal, was a model that was really doing well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

hotspot

WSS

A new nitrogen execution bill also undermines medical licensing

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

How to bring more disabled researchers into academia

R1 RCM gets $5.8 billion buyout offer from private equity firm

hotspot

explore

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The Readout: Amylyx, Alumis, and Lundbeck drug updates

After affirmative action ruling, medical educators look to 'holistic review'

NIH study of ME/CFS points to clear biological hallmarks

Wildfire smoke exposes gaps in outdoor worker protections

A new nitrogen execution bill also undermines medical licensing

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Heart attack and stroke risk calculators need revising

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

knowledge

Change Healthcare payments predicted restored March 15

The Harvard botanist who searched for psychedelics in the Amazon

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

The drug industry has found itself all alone in Washington

hotspot

hotspot

focus

Wikipedia